CHRISTOPHER SISSELL: Open Payments
NPI 1730712605 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 44 payments from 16 companies in 2025. Trend: 2023 $623 · 2024 $1,563 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $145 |
| Exact Sciences Corporation | 5 | $101 |
| Lilly USA, LLC | 6 | $95 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Abbott Laboratories | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: Cologuard Collection Kit, MOUNJARO, Ozempic, Kerendia, REXULTI, SHINGRIX, Wegovy, GARDASIL 9.
Industry payments across LA — which companies pay providers there.
